Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Issue 3 (March 2019)
- Record Type:
- Journal Article
- Title:
- Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Issue 3 (March 2019)
- Main Title:
- Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
- Authors:
- Wolfe, Gil I
Kaminski, Henry J
Aban, Inmaculada B
Minisman, Greg
Kuo, Hui-Chien
Marx, Alexander
Ströbel, Philipp
Mazia, Claudio
Oger, Joel
Cea, J Gabriel
Heckmann, Jeannine M
Evoli, Amelia
Nix, Wilfred
Ciafaloni, Emma
Antonini, Giovanni
Witoonpanich, Rawiphan
King, John O
Beydoun, Said R
Chalk, Colin H
Barboi, Alexandru C
Amato, Anthony A
Shaibani, Aziz I
Katirji, Bashar
Lecky, Bryan R F
Buckley, Camilla
Vincent, Angela
Dias-Tosta, Elza
Yoshikawa, Hiroaki
Waddington-Cruz, Márcia
Pulley, Michael T
Rivner, Michael H
Kostera-Pruszczyk, Anna
Pascuzzi, Robert M
Jackson, Carlayne E
Verschuuren, Jan J G M
Massey, Janice M
Kissel, John T
Werneck, Lineu C
Benatar, Michael
Barohn, Richard J
Tandan, Rup
Mozaffar, Tahseen
Silvestri, Nicholas J
Conwit, Robin
Sonett, Joshua R
Jaretzki, Alfred
Newsom-Davis, John
Cutter, Gary R
Cutter, Gary
Aban, Inmaculada
Minisman, Greg
Feese, Michelle
Kuo, Hui-Chien
Newsom-Davis, John
Wolfe, Gil
Kaminski, Henry
Jaretzki, Alfred
Sonett, Joshua
Mazia, Claudio
Saluto, Valeria
Rosenberg, Moises
Alvarez, Valeria
Rey, Lisa
King, John
Butzkueven, Helmut
Goldblatt, John
Carey, John
Pollard, John
Reddel, Stephen
Handel, Nicholas
McCaughan, Brian
Pallot, Linda
Waddington-Cruz, Márcia
Novis, Ricardo
Boasquevisque, Carlos
Dias-Tosta, Elza
Morato-Fernandez, Rubens
Ximenes, Manoel
Werneck, Lineu
Scola, Rosana
Soltoski, Paulo
Chalk, Colin
Moore, Fraser
Mulder, David
Wadup, Lisa
Oger, Joel
Mezei, Michele
Evans, Kenneth
Jiwa, Theresa
Schaffar, Anne
White, Chris
Toth, Cory
Gelfand, Gary
Wood, Susan
Pringle, Elizabeth
Zwicker, Jocelyn
Maziak, Donna
Shamji, Farid
Sundaresan, Sudhir
Seely, Andrew
Cea, Gabriel
Verduga, Renato
Aguayo, Alberto
Jander, Sebastian
Zickler, Philipp
Klein, Michael
Marx, Alexander
Ströbel, Philipp
Weis, Cleo-Aron
Melms, Arthur
Bischof, Felix
Aebert, Hermann
Ziemer, Gerhard
Nix, Wilfred
Thümler, Björn
Wilhem-Schwenkmezger, Thomas
Mayer, Eckhard
Schalke, Berthold
Pöschel, Peter
Hieber, Gisela
Wiebe, Karsten
Antonini, Giovanni
Clemenzi, Alessandro
Ceschin, Vanessa
Rendina, Erino
Venuta, Federico
Morino, Stefania
Bucci, Elisabetta
Durelli, Luca
Tavella, Alessia
Clerico, Marinella
Contessa, Giulia
Borasio, Piero
Evoli, Amelia
Servidei, Serenella
Granone, Pierluigi
Mantegazza, Renato
Berta, Emilia
Novellino, Lorenzo
Spinelli, Luisa
Motomura, Masakatsu
Matsuo, Hidenori
Nagayasu, Takeshi
Yoshikawa, Hiroaki
Takamori, Masaharu
Oda, Makoto
Matsumoto, Isao
Furukawa, Yutaka
Noto, Daisuke
Motozaki, Yuko
Iwasa, Kazuo
Yanase, Daisuke
Garcia Ramos, Guillermo
Cacho, Bernardo
de la Garza, Lorenzo
Kostera-Pruszczyk, Anne
Lipowska, Marta
Kwiecinski, Hubert
Potulska-Chromik, Anna
Orlowski, Tadeusz
Silva, Ana
Feijo, Marta
Freitas, António
Heckmann, Jeannine
Frost, Andrew
Pan, Edward
Tucker, Lawrence
Rossouw, Johan
Drummond, Fiona
Illa, Isabel
Diaz, Jorge
Leon, Carlos
Yeh, Jiann-Horng
Chiu, Hou-Chang
Hsieh, Yei-San
Witoonpanich, Rawiphan
Tunlayadechanont, Supoch
Attanavanich, Sukasom
Verschuuren, Jan
Straathof, Chiara
Titulaer, Maarten
Versteegh, Michel
Pels, Arda
Krum, Yvonne
Buckley, Camilla
Leite, M. Isabel
Vincent, Angela
Hilton-Jones, David
Ratnatunga, Chandi
Farrugia, Maria
Petty, Richard
Overell, James
Kirk, Alan
Gibson, Andrew
McDermott, Chris
Hopkinson, David
Lecky, Bryan
Watling, David
Marshall, Dot
Saminaden, Sam
Davies, Deborah
Dougan, Charlotte
Sathasivam, Siva
Page, Richard
Sussman, Jon
Ealing, John
Krysiak, Peter
Amato, Anthony
Salajegheh, Mohammad
Jaklitsch, Michael
Roe, Kristen
Ashizawa, Tetsuo
Smith, Robert Glenn
Zwischenberg, Joseph
Stanton, Penny
Barboi, Alexandru
Jaradeh, Safwan
Tisol, William
Gasparri, Mario
Haasler, George
Yellick, Mary
Dennis, Cedric
Barohn, Richard
Pasnoor, Mamatha
Dimachkie, Mazen
McVey, April
Gronseth, Gary
Dick, Arthur
Kramer, Jeffrey
Currence, Melissa
Herbelin, Laura
Belsh, Jerry
Li, George
Langenfeld, John
Mertz, Mary Ann
Benatar, Michael
Harrison, Taylor
Force, Seth
Usher, Sharon
Beydoun, Said
Lin, Frank
DeMeester, Steve
Akhter, Salem
Malekniazi, Ali
Avenido, Gina
Crum, Brian
Milone, Margherita
Cassivi, Stephen
Fisher, Janet
Ciafaloni, Emma
Heatwole, Chad
Watson, Thomas
Hilbert, James
Smirnow, Alexis
Distad, B. Jane
Weiss, Michael
Wood, Douglas
Haug, Joanna
Ernstoff, Raina
Cao, Jingyang
Chmielewski, Gary
Welsh, Robert
Duris, Robin
Gutmann, Laurie
Pawar, Gauri
Graeber, Geoffrey Marc
Altemus, Patricia
Nance, Christopher
Gutmann, Ludwig
Jackson, Carlayne
Grogan, Patrick
Calhoon, John
Kittrell, Pamela
Myers, Deborah
Hayat, Ghazala
Naunheim, Keith
Eller, Susan
Holzemer, Eve
Katirji, Bashar
Alshekhlee, Amer
Robke, Jason
Karlinchak, Brenda
Katz, Jonathan
Miller, Robert
Roan, Ralph
Forshew, Dallas
Kissel, John
Elsheikh, Bakri
Ross, Patrick
Chelnick, Sharon
Lewis, Richard
Acsadi, Agnes
Baciewicz, Frank
Masse, Stacey
Massey, Janice
Juel, Vern
Onaitis, Mark
Lowe, James
Lipscomb, Bernadette
Mozaffar, Tahseen
Thai, Gaby
Milliken, Jeffrey
Martin, Veronica
Karayan, Ronnie
Muley, Suraj
Parry, Gareth
Shumway, Sara
Oh, Shin
Claussen, Gwen
Lu, Liang
Cerfolio, Robert
Young, Angela
Morgan, Marla
Pascuzzi, Robert
Kincaid, John
Kesler, Kenneth
Guingrich, Sandy
Michaels, Angi
Phillips, Lawrence
Burns, Ted
Jones, David
Fischer, Cindy
Pulley, Michael
Berger, Alan
D'Agostino, Harry
Smith, Lisa
Rivner, Michael
Pruitt, Jerry
Landolfo, Kevin
Hillman, Demetric
Shaibani, Aziz
Sermas, Angelo
Ruel, Ross
Ismail, Farah
Sivak, Mark
Goldstein, Martin
Camunas, Jorge
Bratton, Joan
Tandan, Rup
Panitch, Hill
Leavitt, Bruce
Jones, Marilee
Muppidi, Srikanth
Vernino, Steven
Nations, Sharon
Meyer, Dan
Gorham, Nina
… (more) - Abstract:
- Summary: Background: The Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone (MGTX) showed that thymectomy combined with prednisone was superior to prednisone alone in improving clinical status as measured by the Quantitative Myasthenia Gravis (QMG) score in patients with generalised non-thymomatous myasthenia gravis at 3 years. We investigated the long-term effects of thymectomy up to 5 years on clinical status, medication requirements, and adverse events. Methods: We did a rater-blinded 2-year extension study at 36 centres in 15 countries for all patients who completed the randomised controlled MGTX and were willing to participate. MGTX patients were aged 18 to 65 years at enrolment, had generalised non-thymomatous myasthenia gravis of less than 5 years' duration, had acetylcholine receptor antibody titres of 1·00 nmol/L or higher (or concentrations of 0·50–0·99 nmol/L if diagnosis was confirmed by positive edrophonium or abnormal repetitive nerve stimulation, or abnormal single fibre electromyography), had Myasthenia Gravis Foundation of America Clinical Classification Class II–IV disease, and were on optimal anticholinesterase therapy with or without oral corticosteroids. In MGTX, patients were randomly assigned (1:1) to either thymectomy plus prednisone or prednisone alone. All patients in both groups received oral prednisone at doses titrated up to 100 mg on alternate days until they achieved minimal manifestation status. The primarySummary: Background: The Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone (MGTX) showed that thymectomy combined with prednisone was superior to prednisone alone in improving clinical status as measured by the Quantitative Myasthenia Gravis (QMG) score in patients with generalised non-thymomatous myasthenia gravis at 3 years. We investigated the long-term effects of thymectomy up to 5 years on clinical status, medication requirements, and adverse events. Methods: We did a rater-blinded 2-year extension study at 36 centres in 15 countries for all patients who completed the randomised controlled MGTX and were willing to participate. MGTX patients were aged 18 to 65 years at enrolment, had generalised non-thymomatous myasthenia gravis of less than 5 years' duration, had acetylcholine receptor antibody titres of 1·00 nmol/L or higher (or concentrations of 0·50–0·99 nmol/L if diagnosis was confirmed by positive edrophonium or abnormal repetitive nerve stimulation, or abnormal single fibre electromyography), had Myasthenia Gravis Foundation of America Clinical Classification Class II–IV disease, and were on optimal anticholinesterase therapy with or without oral corticosteroids. In MGTX, patients were randomly assigned (1:1) to either thymectomy plus prednisone or prednisone alone. All patients in both groups received oral prednisone at doses titrated up to 100 mg on alternate days until they achieved minimal manifestation status. The primary endpoints of the extension phase were the time-weighted means of the QMG score and alternate-day prednisone dose from month 0 to month 60. Analyses were by intention to treat. The trial is registered with ClinicalTrials.gov, number NCT00294658 . It is closed to new participants, with follow-up completed. Findings: Of the 111 patients who completed the 3-year MGTX, 68 (61%) entered the extension study between Sept 1, 2009, and Aug 26, 2015 (33 in the prednisone alone group and 35 in the prednisone plus thymectomy group). 50 (74%) patients completed the 60-month assessment, 24 in the prednisone alone group and 26 in the prednisone plus thymectomy group. At 5 years, patients in the thymectomy plus prednisone group had significantly lower time-weighted mean QMG scores (5·47 [SD 3·87] vs 9·34 [5·08]; p=0·0007) and mean alternate-day prednisone doses (24 mg [SD 21] vs 48 mg [29]; p=0·0002) than did those in the prednisone alone group. 14 (42%) of 33 patients in the prednisone group, and 12 (34%) of 35 in the thymectomy plus prednisone group, had at least one adverse event by month 60. No treatment-related deaths were reported during the extension phase. Interpretation: At 5 years, thymectomy plus prednisone continues to confer benefits in patients with generalised non-thymomatous myasthenia gravis compared with prednisone alone. Although caution is appropriate when generalising our findings because of the small sample size of our study, they nevertheless provide further support for the benefits of thymectomy in patients with generalised non-thymomatous myasthenia gravis. Funding: National Institutes of Health, National Institute of Neurological Disorders and Stroke. … (more)
- Is Part Of:
- Lancet neurology. Volume 18:Issue 3(2019)
- Journal:
- Lancet neurology
- Issue:
- Volume 18:Issue 3(2019)
- Issue Display:
- Volume 18, Issue 3 (2019)
- Year:
- 2019
- Volume:
- 18
- Issue:
- 3
- Issue Sort Value:
- 2019-0018-0003-0000
- Page Start:
- 259
- Page End:
- 268
- Publication Date:
- 2019-03
- Subjects:
- Neurology -- Periodicals
Neurology -- Periodicals
Nervous System Diseases -- Periodicals
Neurologie -- Périodiques
Neurology
Electronic journals
Periodicals
616.805 - Journal URLs:
- http://www.thelancet.com/journals/laneur ↗
http://www.sciencedirect.com/science/journal/14744422 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S1474-4422(18)30392-2 ↗
- Languages:
- English
- ISSNs:
- 1474-4422
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.084000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 18819.xml